THE TREATMENT OF DIFFUSE BENIGN BREAST DISEASE AND MASTODYNIA
https://doi.org/10.17749/2070-4968.2015.9.3.022-027
Abstract
Objective. A study of the effectiveness of drugs Mastopol in the treatment of diffuse benign breast disease and mastodynia. Materials and methods. The patient underwent a comprehensive examination of the breast.Treatment was carried out one of the successfully used medications for the treatment of diffuse benign breast disease, non-hormonal homeopathic remedy plant origin Mastopol. Indications for the use of Mostopol is a comprehensive treatment of fibrocystic mastopathy, mastodynia. Results. We examined 45 women aged 30-44 years, who appealed with complaints of pain in both breast. All the patients underwent a comprehensive examination, which included clinical examination, mammography, sonography of the breast and axillary regions. The entire group was discovered fibrocystic breast disease of different forms and degrees of severity. All the patients had been appointed Mastopol in standard doses. After one course of treatment (8 weeks), 43 (95,5%) patients noted a positive effect. 29 (65%) patients noted marked improvement of health, reduction or disappearance of mastalgia. 14(35%) patients emphasized the reduction of intensity of premenstrual syndrome. Conclusions. The results of these studies showed high efficacy Mastopol in the treatment of mastalgia and diffuse benign changes in the breast.The positive dynamics was achieved quickly and efficiently in most cases (95.5 percent). Signs of mastodynia were resolved after a single course of treatment. Two courses of conservative therapy yielded positive results, confirmed by objective clinical data and research sonography of the breast. The reduction of the size of cysts, reduction in the density and swelling of the breast tissue. The use of the drug Mastopol no identified side effects. Mastopol can be widely recommended for the treatment of mastodynia and diffuse benign disease (mastopathy).
About the Authors
N. I. Rozhkova
Moscow Research Institute of Oncology named after PA Herzen Ministry of Health of Russia, Moscow
Russian Federation
MD, Professor, Director
Russian Federation
MD, Professor, Director
I. I. Burdina
Moscow Research Institute of Oncology named after PA Herzen Ministry of Health of Russia, Moscow
Russian Federation
PhD, senior researche
Russian Federation
PhD, senior researche
S. B. Zapirova
Moscow Research Institute of Oncology named after PA Herzen Ministry of Health of Russia, Moscow
Russian Federation
PhD, senior researche
Russian Federation
PhD, senior researche
M. L. Mazo
Moscow Research Institute of Oncology named after PA Herzen Ministry of Health of Russia, Moscow
Russian Federation
PhD, senior researche
Russian Federation
PhD, senior researche
S. P. Prokopenko
Moscow Research Institute of Oncology named after PA Herzen Ministry of Health of Russia, Moscow
Russian Federation
PhD, senior researche
Russian Federation
PhD, senior researche
O. E. Yakobs
Moscow Research Institute of Oncology named after PA Herzen Ministry of Health of Russia, Moscow
Russian Federation
PhD, senior researche
Russian Federation
PhD, senior researche
References
1. Balan V.E. Consilium medicum. 2007; 6: 80-84.
2. Burdina L.M. Clinical and radiological features of breast diseases in gynecological patients of reproductive age with neuroendocrine pathology. Dr. diss. [Kliniko-rentgenologicheskie osobennosti zabolevanii molochnykh zhelez u ginekologicheskikh bol'nykh reproduktivnogo vozrasta s neiroendokrinnoi patologiei. Diss. …dokt. med. nauk (in Russian)]. Moscow. 1993.
3. Burdina L.M. Mammologiya. 1993; 1: 4-11.
4. Ledina A.V., Prilepskaya V.N. Ginekologiya. 2011; 13 (5): 66-69.
5. Prilepskaya V.N., Volobuev A.I., Shvetsova O.B. Ginekologiya. 2003; 5 (4): 20-24.
6. Rozhkova N.I., Burdina I.I. Clinical and pathological characteristics of X-ray diffuse and treatment of benign breast disease (mastopathy): A Practical Guide [Kliniko-rentgeno-patomorfologicheskaya kharakteristika i lechenie diffuznykh dobrokachestvennykh zabolevanii molochnoi zhelezy (mastopatii): Prakticheskoe rukovodstvo (in Russian)]. Moscow. 2010.
7. Rozhkova N.I., Kharchenko V.P.Methods of diagnosis of breast disease. Mammalogy: national leadership [Metody diagnostiki zabolevanii molochnoi zhelezy. Mammologiya: natsional'noe rukovodstvo (in Russian)]. Moscow. 2009; 29-100.
8. Rozhkova N.I., Burdina N.I., Meskikh E.V. Diffuse benign breast disease. Diagnosis and Treatment: A Guide for Physicians [Diffuznye dobrokachestvennye zabolevaniya molochnoi zhelezy. Diagnostika i lechenie: rukovodstvo dlya vrachei (in Russian)]. Moscow2012.
9. Rozhkova N.I. Radiation diagnostics in breast care: a guide for doctors [Luchevaya diagnostika v mammologii: rukovodstvo dlya vrachei (in Russian)]. Moscow. 2014.
10. Smetnik V.P., Burdina L.M. Methods of treatment of diffuse benign breast disease. Mammalogy: national leadership [Metody lecheniya diffuznykh dobrokachestvennykh zabolevanii molochnoi zhelezy. Mammologiya: natsional'noerukovodstvo (in Russian)]. Moscow. 2009; 319-324.
11. Tagieva G.T. Ginekologiya. 2004; 6 (5): 228-230.
12. Biswas R. et al. Thujon-Rich Fraction of Thuja occidettalis Demonstrates Major Anti-Cancer Potentials: Evidence from In Vitro Studies on A375 Cells. Evid. Based. Complement Alternat. Med. 2011; 568148.
13. Breast pain: mastalgia is common but often manageable. Mayo Clin Health Lett. 2000; 18 (4): 6.
14. Shang L.C. et. Bioactive constituents of Thuja occidentalis. J. NatProd. 2000; 63 (9): 1235- 1238.
Review
For citations:
Rozhkova N.I., Burdina I.I., Zapirova S.B., Mazo M.L., Prokopenko S.P., Yakobs O.E. THE TREATMENT OF DIFFUSE BENIGN BREAST DISEASE AND MASTODYNIA. Obstetrics, Gynecology and Reproduction. 2015;9(3):22-27. (In Russ.) https://doi.org/10.17749/2070-4968.2015.9.3.022-027
Views: 1018
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Email this article 
